Ingevity Past Earnings Performance
Past criteria checks 0/6
Ingevity's earnings have been declining at an average annual rate of -6.3%, while the Chemicals industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 8.8% per year.
Key information
-6.3%
Earnings growth rate
-3.8%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | 8.8% |
| Return on equity | -0.9% |
| Net Margin | -0.3% |
| Next Earnings Update | 01 May 2024 |
Recent past performance updates
Recent updates
Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?
Apr 18
Is Ingevity (NYSE:NGVT) A Risky Investment?
Mar 22What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?
Jan 23Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares
Jan 04These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts
Nov 10Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?
Oct 07Ingevity Corporation: The Risk To Reward Is Currently Favorable
Oct 06Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Sep 22Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?
Aug 11Ingevity Corporation: Headwinds Are Temporary
Jul 05Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Jun 21Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?
May 29We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
Feb 16Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?
Jan 25Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate
Sep 13Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?
Aug 22Ingevity to acquire pavement marking materials business Ozark Materials for $325M
Aug 02Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly
Aug 01Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends
Jun 05What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?
May 20Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist
May 03We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
May 02Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital
Mar 03We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
Jan 19Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 42%?
Dec 06Be Wary Of Ingevity (NYSE:NGVT) And Its Returns On Capital
Nov 18Is Ingevity (NYSE:NGVT) A Risky Investment?
Oct 04An Intrinsic Calculation For Ingevity Corporation (NYSE:NGVT) Suggests It's 38% Undervalued
Sep 04Investors Met With Slowing Returns on Capital At Ingevity (NYSE:NGVT)
Aug 20If You Like EPS Growth Then Check Out Ingevity (NYSE:NGVT) Before It's Too Late
Aug 05Ingevity (NYSE:NGVT) Has A Pretty Healthy Balance Sheet
Jun 28Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 25% Undervaluation?
May 22Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital
May 04Ingevity Corporation 2021 Q1 - Results - Earnings Call Presentation
Apr 30Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Ingevity makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,692 | -5 | 184 | 32 |
| 30 Sep 23 | 1,704 | 127 | 196 | 32 |
| 30 Jun 23 | 1,740 | 177 | 210 | 32 |
| 31 Mar 23 | 1,678 | 202 | 207 | 32 |
| 31 Dec 22 | 1,668 | 212 | 198 | 30 |
| 30 Sep 22 | 1,621 | 225 | 191 | 30 |
| 30 Jun 22 | 1,516 | 146 | 181 | 29 |
| 31 Mar 22 | 1,454 | 130 | 179 | 27 |
| 31 Dec 21 | 1,392 | 118 | 179 | 26 |
| 30 Sep 21 | 1,381 | 135 | 169 | 25 |
| 30 Jun 21 | 1,336 | 209 | 160 | 24 |
| 31 Mar 21 | 1,248 | 185 | 151 | 23 |
| 31 Dec 20 | 1,216 | 181 | 150 | 23 |
| 30 Sep 20 | 1,194 | 180 | 153 | 22 |
| 30 Jun 20 | 1,222 | 170 | 159 | 21 |
| 31 Mar 20 | 1,304 | 206 | 163 | 21 |
| 31 Dec 19 | 1,293 | 184 | 163 | 20 |
| 30 Sep 19 | 1,268 | 182 | 158 | 20 |
| 30 Jun 19 | 1,219 | 171 | 152 | 21 |
| 31 Mar 19 | 1,175 | 161 | 145 | 22 |
| 31 Dec 18 | 1,134 | 169 | 133 | 22 |
| 30 Sep 18 | 1,085 | 169 | 125 | 22 |
| 30 Jun 18 | 1,037 | 153 | 116 | 21 |
| 31 Mar 18 | 989 | 138 | 107 | 20 |
| 31 Dec 17 | 972 | 127 | 107 | 20 |
| 30 Sep 17 | 954 | 94 | 104 | 19 |
| 30 Jun 17 | 942 | 53 | 103 | 18 |
| 31 Mar 17 | 927 | 45 | 100 | 18 |
| 31 Dec 16 | 908 | 35 | 96 | 18 |
| 30 Sep 16 | 898 | 34 | 93 | 13 |
| 30 Jun 16 | 902 | 64 | 95 | 9 |
| 31 Mar 16 | 919 | 66 | 105 | 5 |
| 31 Dec 15 | 958 | 80 | 93 | 17 |
| 30 Sep 15 | 999 | 99 | 107 | 8 |
| 30 Jun 15 | 1,025 | 115 | 108 | 8 |
| 31 Mar 15 | 1,022 | 121 | 104 | 8 |
| 31 Dec 14 | 1,036 | 129 | 108 | 0 |
| 31 Dec 13 | 980 | 119 | 92 | 11 |
Quality Earnings: NGVT is currently unprofitable.
Growing Profit Margin: NGVT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NGVT is unprofitable, and losses have increased over the past 5 years at a rate of 6.3% per year.
Accelerating Growth: Unable to compare NGVT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NGVT is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-11.9%).
Return on Equity
High ROE: NGVT has a negative Return on Equity (-0.86%), as it is currently unprofitable.